Your browser doesn't support javascript.
loading
Clinical implications of partial anomalous pulmonary venous connection: a rare cause of severe pulmonary arterial hypertension.
Pizzini, Alex; Sonnweber, Thomas; Frank, Renate; Theurl, Markus; Weiss, Günter; Tancevski, Ivan; Löffler-Ragg, Judith.
Affiliation
  • Pizzini A; Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, Innsbruck, Austria.
  • Sonnweber T; Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, Innsbruck, Austria.
  • Frank R; Department of Radiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Theurl M; Department of Internal Medicine III (Cardiology, Angiology), Medical University of Innsbruck, Innsbruck, Austria.
  • Weiss G; Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, Innsbruck, Austria.
  • Tancevski I; Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, Innsbruck, Austria.
  • Löffler-Ragg J; Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, Innsbruck, Austria.
Pulm Circ ; 10(1): 2045894019885352, 2020.
Article in En | MEDLINE | ID: mdl-32257114
Isolated partial anomalous pulmonary venous connection (PAPVC) is an uncommon congenital heart anomaly that is sporadically associated with pulmonary arterial hypertension in the adult population. The diagnosis and therapy for this condition are challenging. We report on three cases of patients with unexpected severe precapillary pulmonary hypertension in single PAPVC treated with an upfront pulmonary arterial hypertension-specific combination therapy. Our cases indicate that the combination of PAPVC and pulmonary comorbidities may trigger the development of severe pulmonary arterial hypertension. The initiation of pulmonary arterial hypertension-targeted combination therapy revealed to be a safe and efficacious strategy for patients with PAPVC-associated severe pulmonary arterial hypertension.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pulm Circ Year: 2020 Document type: Article Affiliation country: Austria Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pulm Circ Year: 2020 Document type: Article Affiliation country: Austria Country of publication: United States